Dr. Aris N Economides received his
Ph.D. in Biochemistry from Michigan State University in 1992 and promptly
joined Regeneron Pharmaceuticals. He currently holds the position of Vice
President, leading two groups: Synthetic Biology and Cell Engineering Technologies, and Connective Tissue Diseases Therapeutic Focus Area. In addition, he is a co-founder of Regeneron
Genetics Center (RGC). He
co-invented Cytokine Traps, VelociGene®, and VelocImmune®, all part of an
integrated methodology for target discovery, validation, and the generation of
biologic drugs such as the IL1 and VEGF traps, as well as therapeutic
antibodies. He has had a long standing interest in elucidate the molecular pathophysiology of genetically-driven disorders, and using this information to develop therapies.
Dr. Aris N Economides received his
Ph.D. in Biochemistry from Michigan State University in 1992 and promptly
joined Regeneron Pharmaceuticals. He currently holds the position of Vice
President, leading two groups: Synthetic Biology and Cell Engineering Technologies, and Connective Tissue Diseases Therapeutic Focus Area. In addition, he is a co-founder of Regeneron
Genetics Center (RGC). He
co-invented Cytokine Traps, VelociGene®, and VelocImmune®, all part of an
integrated methodology for target discovery, validation, and the generation of
biologic drugs such as the IL1 and VEGF traps, as well as therapeutic
antibodies. He has had a long standing interest in elucidate the molecular pathophysiology of genetically-driven disorders, and using this information to develop therapies.